Trial Profile
A Phase II Study of Milataxel (TL139) Administered Orally or Intravenously in Taxane Naive Patients with Metastatic Breast Cancer.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2016
Price :
$35
*